Survivors of severe SARS-CoV-2 infections frequently suffer from a range of post-infection sequelae. Whether survivors of mild or asymptomatic infections can expect any long-term health consequences is not yet known. Herein we investigated lasting changes to soluble inflammatory factors and cellular immune phenotype and function in individuals who had recovered from mild SARS-CoV-2 infections (n = 22), compared to those that had recovered from other mild respiratory infections (n = 11). Individuals who had experienced mild SARS-CoV-2 infections had elevated levels of C-reactive protein 1–3 months after symptom onset, and changes in phenotype and function of circulating T-cells that were not apparent in individuals 6–9 months post-symptom onset. Markers of monocyte activation, and expression of adherence and chemokine receptors indicative of altered migratory capacity, were also higher at 1–3 months post-infection in individuals who had mild SARS-CoV-2, but these were no longer elevated by 6–9 months post-infection. Perhaps most surprisingly, significantly more T-cells could be activated by polyclonal stimulation in individuals who had recently experienced a mild SARS-CoV-2, infection compared to individuals with other recent respiratory infections. These data are indicative of prolonged immune activation and systemic inflammation that persists for at least three months after mild or asymptomatic SARS-CoV-2 infections.
The magnitude of eosinophil mobilization into respiratory tissues drives the severity of inflammation in several airway diseases. In classical models of leukocyte extravasation, surface integrins undergo conformational switches to high-affinity states via chemokine binding activation. Recently, we learned that eosinophil integrins possess mechanosensitive properties that detect fluid shear stress, which alone was sufficient to induce activation. This mechanical stimulus triggered intracellular calcium release and hallmark migration-associated cytoskeletal reorganization including flattening for increased cell–substratum contact area and pseudopodia formation. The present study utilized confocal fluorescence microscopy to investigate the effects of pharmacological inhibitors to calcium signaling and actin polymerization pathways on shear stress-induced migration in vitro. Morphological changes (cell elongation, membrane protrusions) succeeded the calcium flux in untreated eosinophils within 2 min, suggesting that calcium signaling was upstream of actin cytoskeleton rearrangement. The inhibition of ryanodine receptors and endomembrane Ca2+-ATPases corroborated this idea, indicated by a significant increase in time between the calcium spike and actin polymerization. The impact of the temporal link is evident as the capacity of treated eosinophils to move across fibronectin-coated surfaces was significantly hampered relative to untreated eosinophils. Furthermore, we determined that the nature of cellular motility in response to fluid shear stress was nondirectional.
Survivors of severe SARS-CoV-2 infections frequently suffer from a range of post-infection sequelae. Whether survivors of mild or asymptomatic infections can expect any long-term health consequences is not yet known. Herein we investigated lasting changes to soluble inflammatory factors and cellular immune phenotype and function in individuals who had recovered from mild SARS-CoV-2 infections (n=22) compared to those that had recovered from other mild respiratory infections (n=11). Individuals who had mild SARS-CoV-2 infections had elevated levels of C-reactive protein 1-3 months after symptom onset, and changes in phenotype and function of circulating T cells that were not apparent in individuals 6-9 months post-symptom onset. Markers of monocyte activation and expression of adherence and chemokine receptors indicative of altered migratory capacity were also higher at 1-3 months post-infection in individuals who had mild SARS-CoV-2, but these were no longer elevated by 6-9 months post-infection. Perhaps most surprisingly, polyclonal activation of T cells was higher in individuals who had recently experienced a mild SARS-CoV-2 infection compared to individuals with other recent respiratory infections. These data are indicative of prolonged immune activation and systemic inflammation that persists for up to three months after mild or asymptomatic SARS-CoV-2 infections.
Rationale: Airway autoantibodies induce histone-coated eosinophil extracellular traps (EETs). EETs are associated with free eosinophil granules (FEGs) and galectin-10 which autocrystallize ex vivo to form Charcot-Leyden crystals (CLCs). Objective: To investigate cytokines and autoimmune responses in patients with CLCs. Methods: Between 2020-2022, CLCs and cell differentials were routinely reported for processed sputum. Cell-free supernatants were assessed for antinuclear antibodies (HUMAN Diagnostics, PMID 28751233), cytokines (EllaTM, Protein Simple), and danger-associated molecular patterns (DAMPs): high mobility box group 1 (HMGB1) and galectin-10 proteins (Novus Biologicals). Results: CLCs were reported in 61/3075 (2%) processed sputa slides (protocol: PMID 8804934). All 46 CLC+ samples with adequate volume and confirmed severe asthma diagnosis were eosinophilic (≥3% eos±FEGs) and comprised the Eos+CLC+ group. Additionally, Eos+CLC- (n=53) and Eos-CLC- (n=32) were included for analysis. Eos+CLC+ had increased ANAs vs CLC- groups (P<0.005, Fig 1A). Reactivities against anti-histone IgG were higher in Eos+CLC+ (96%) vs. Eos-CLC- (30%) (Fig 1B). Eos+CLC+ had higher T2 inflammation (IL-4, IL-5, IL-13, P<0.05), HMGB1 (Fig 1C), and decreased trend for “free” galactin-10 compared to CLC- sputa. Conclusions: We report that severe asthma patients with CLCs have high autoimmune burden marked by DAMPs and autoantibodies.